Jorge Goldstein is a founding director of Sterne Kessler Goldstein and Fox, PLLC, a 400-plus person IP law firm in Washington DC. He has 48 years of experience in preparing, prosecuting, licensing, enforcing, and litigating biotech patents. Noteworthy among several of his appellate U.S. cases, in 1988 Goldstein was lead counsel in In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement.

He received a BS in Chemistry from RPI in 1971, a PhD in Chemistry from Harvard in 1976, and a JD from the George Washington University in 1982. In 2017 he was inducted into the LMG Life Sciences Hall of Fame and in 2025 he received the Lifetime Achievement Award from Life Sciences Patent Network.

Goldstein’s prior publications on the topic of patent pools in biotechnology include:

• Jorge A. Goldstein, “Biotechnology patent pools and standards setting,” Chapter 25 in Patent Law and Theory – a Handbook of Contemporary Research (Edward Elgar, Cheltenham, UK 2008; Toshiko Takenaka, ed.): 713-721
• Ebersole, T.J., Guthrie, M.C., and Jorge Goldstein, “Patent Pools as a Solution to the Licensing Problems of Diagnostic Genetics,” Intellectual Property & Technology Law Journal, Vol. 17, No. 1: 6-11 (2005)

Additional publications from the last few years include:

• Book: Jorge Goldstein, 미국 생명공학 특허법 U.S. Biotechnology Patent Law. Translated by Kim Mi-kyung, et al. (Park Young Sa Co., Ltd., 2025).
• Book: Jorge Goldstein, Patenting Life – Tales from the Frontlines of Intellectual Property and the New Biology (Georgetown University Press, 2025).
• Book: Jorge Goldstein, U.S. Biotechnology Patent Law, Cases and Comments for Beginning and Experienced Practitioners (Thomson Reuters, 10th ed. 2025-2026).
• Jorge Goldstein and Haley Ball, “Prima Facie Lack Of Novelty: When Prior Art Ranges Give Rise To Rebuttable Anticipation,” AIPLA Quarterly Journal (in the press, Spring, 2025)
• Jorge Goldstein, “Solutions to the Problem of Therapeutic Antibody Genus Claims,” 52 AIPLA Quarterly Journal 513 (Summer, 2024)